Adicet Bio, Inc. — Director's Dealing 2023

Feb 14, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Adicet Bio, Inc. (ACET)
CIK: 0001720580
Period of Report: 2023-02-10

Reporting Person: Healey Don (Chief Technology Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-02-10	Common Stock	S	10467	$7.9752	Disposed	71101	Direct

Footnotes

F1: The sales reported in this Form 4 were effected to fund tax obligations related to PSUs and RSUs that vested in 2022 pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 11, 2023.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $7.855 to $8.06, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Securities and Exchange Commission staff upon request.